The Unilever dry shampoo recall remains one of the most closely watched product liability events in recent consumer safety history. What began as a voluntary recall in October 2022 has since grown into a $3.625 million federal class action settlement involving some of the most recognizable hair care brands in America such as Dove, TRESemme, Suave, Nexxus, and TIGI (Bed Head and Rockaholic).
At the center of the controversy is benzene, a known human carcinogen classified by the International Agency for Research on Cancer (IARC), the National Cancer Institute, and the CDC as a direct cause of leukemia and other blood-related cancers. For attorneys handling dry shampoo mass tort cases and product liability claims, understanding the full scope of the recall, the litigation landscape, and the evidentiary requirements is not just helpful, it is essential to building winning cases.
This article covers everything attorneys need to know: the recall timeline, affected brands, current lawsuit status, the role of benzene in toxic injury claims, and how medical record review, chronology, and narrative summary services directly strengthen your legal strategy.
Handling a Unilever Dry Shampoo or Benzene Injury Case?
Overview of the Unilever Dry Shampoo Recall
In October 2022, Unilever United States issued a sweeping voluntary recall of 19 aerosol dry shampoo product lines after internal testing confirmed the presence of benzene, a volatile organic compound and known human carcinogen in the propellant systems of affected products. The U.S. Food and Drug Administration (FDA) published the official recall notice on October 21, 2022, and affected products were removed from retail shelves nationwide.
The contamination was traced to the hydrocarbon propellant specifically butane and propane blends sourced from third-party supplier Aeropres Corporation. Unilever’s contract filler, Voyant Beauty LLC, was also later named in litigation as a contributing party in the supply chain failure.
Key Brands and Products Affected
The recall covered aerosol dry shampoo products manufactured before October 2021, sold under the following Unilever-owned or distributed brands:
| Brand | Products Recalled | Notes |
| Dove | Aerosol dry shampoo variants | Part of 1,559,190 recalled cases |
| TRESemme | Aerosol dry shampoo lines | Part of 1,559,190 recalled cases |
| Suave | Aerosol dry shampoo range | Part of 1,559,190 recalled cases |
| Nexxus | Aerosol dry shampoo products | Part of 1,559,190 recalled cases |
| TIGI – Bed Head | Specific aerosol SKUs | Part of 559,844 recalled units |
| TIGI – Rockaholic | Specific aerosol SKUs | Part of 559,844 recalled units |
The FDA ultimately categorized the Unilever recall as a Class II recall in June 2024, indicating that while the probability of serious adverse health consequences was considered remote, the presence of a confirmed carcinogen in consumer products warranted corrective action.
Recall Timeline: From Discovery to Settlement
| Date | Key Event |
| Early 2021 | Benzene found in aerosol antiperspirants; industry-wide awareness begins |
| July 2021 | Unilever gains awareness of benzene risk as competitor recalls begin |
| November 2021 | Independent lab Valisure submits FDA citizen petition confirming benzene in aerosol products |
| October 18, 2022 | Unilever issues voluntary recall of 19 aerosol dry shampoo products; FDA notified |
| October 21, 2022 | FDA publishes official recall notice on its website |
| November 2022 | Class action filed: Little et al. v. Unilever United States (D. Conn., Case No. 3:22-cv-01189) |
| 2023 | Voyant Beauty LLC and Aeropres Corporation named as additional defendants |
| June 2024 | FDA officially categorizes recall as Class II |
| Early 2025 | Plaintiffs move for preliminary court approval of $3.625 million settlement |
| Ongoing 2025 | Settlement covers purchases between January 1, 2014 and December 31, 2022 |
Benzene Health Risks: What Attorneys Need to Know
Understanding the toxicology of benzene exposure is fundamental to building a credible product liability case. Benzene is a colorless, flammable liquid found naturally in crude oil and gasoline. In the context of aerosol dry shampoos, consumers were unknowingly exposed through three primary routes:
- Inhalation: Breathing in aerosolized benzene particles during product application
- Dermal absorption: Benzene penetrating the scalp and skin during topical use
- Incidental ingestion: Residual product contact near the mouth or face
According to the CDC and the Department of Health and Human Services (DHHS), long-term benzene exposure generally defined as one year or more is directly associated with the following health conditions relevant to injury litigation:
- Acute myeloid leukemia (AML) the most well-established benzene-related cancer
- Chronic lymphocytic leukemia (CLL)
- Non-Hodgkin lymphoma and multiple myeloma
- Aplastic anemia a serious blood disorder involving bone marrow failure
- Myelodysplastic syndrome (MDS) a precancerous bone marrow condition
- Decreased red and white blood cell counts leading to anemia and immune deficiency
- Irregular menstrual cycles and reduced ovarian function in women with prolonged exposure
Legal Landscape: Unilever Dry Shampoo Lawsuits and Settlements
Filed in the U.S. District Court for the District of Connecticut, this landmark case represents the primary consolidated litigation arising from the Unilever dry shampoo recall. Plaintiff Elizabeth Little and other consumers alleged the following legal violations:
- Product liability: Defective product causing harm to consumers
- Failure to warn: Inadequate disclosure of benzene contamination risk
- Negligence: Failure to implement proper quality control and supply chain oversight
- Breach of warranty: Products failed to meet implied and express safety standards
- Unjust enrichment: Consumers paid for products that were unsafe for intended use
- Violations of state and federal consumer protection statutes
By 2025, plaintiffs had secured preliminary motion for court approval of a $3.625 million settlement covering all U.S. consumers who purchased affected Unilever dry shampoo products between January 1, 2014, and December 31, 2022. Claimants can receive up to $3 per product without proof of purchase (capped at four products per household) or full refunds with valid receipts.
Types of Dry Shampoo Benzene Claims Attorneys Can Pursue
| Claim Type | Legal Basis | Key Evidence Needed |
| Personal Injury / Cancer Diagnosis | Strict product liability, negligence | Medical records confirming diagnosis + exposure history |
| Wrongful Death | Negligence, product defect | Death certificate, medical records, product use evidence |
| Consumer Fraud / Class Action | State consumer protection laws | Proof of purchase within recall class period |
| Failure to Warn | Tort law, inadequate labeling | Product labels, Unilever internal communications |
| Mass Tort Coordination | MDL consolidation strategy | Medical record chronology, narrative summaries per plaintiff |
Managing Multiple Plaintiff Records in a Dry Shampoo Mass Tort?
The Role of Medical Record Review in Dry Shampoo Litigation
In benzene-related product liability cases, the medical record is your most powerful evidentiary asset. Unlike cases with immediate, observable injuries, benzene exposure claims involve a latency period the time gap between exposure and symptom onset that can span months to decades. This makes thorough, professionally organized medical documentation not just helpful, but legally indispensable.
How Medical Record Review Strengthens Your Case?
A comprehensive medical record review conducted by experienced medico-legal professionals helps attorneys achieve the following critical litigation:
- Establish exposure timelines: Correlating the period of dry shampoo use with onset of blood disorders or cancer diagnoses
- Document the latency period: Proving the progression from benzene exposure to verifiable health damage
- Rule out alternative causes: Differentiating benzene-induced conditions from pre-existing or unrelated diagnoses
- Support expert medical testimony: Providing organized, fact-checked records that expert witnesses can rely on
- Quantify damages: Establishing the extent of medical treatment, prognosis, and economic losses tied to the injury
- Counter defense challenges: Pre-empting defense arguments about pre-existing conditions or alternative exposures
What a Medico-Legal Chronology Includes for Benzene Cases?
A well-constructed medical chronology for a Unilever dry shampoo case typically covers:
- Documented dates of dry shampoo product use and purchase history
- Initial presentation of symptoms: Fatigue, unusual bruising, recurrent infections
- All physician visits, specialist referrals (oncologist, hematologist), and emergency encounters
- Diagnostic workups: Complete blood counts (CBCs), bone marrow biopsies, imaging studies
- Cancer or blood disorder diagnosis date and clinical staging
- Treatment records: Chemotherapy, radiation, bone marrow transplant, hospitalization
- Ongoing care, prognosis reports, and quality-of-life documentation
Narrative Summary: Turning Medical Records into Legal Arguments
Beyond chronology, a medical narrative summary translates complex clinical information into a coherent legal story. For juries, judges, and mediators, a clear narrative connecting a plaintiff’s use of benzene-contaminated Dove, Suave, or TRESemme dry shampoo to a leukemia diagnosis is far more persuasive than raw medical charts.
Frequently Asked Questions
Is benzene exposure from dry shampoo linked to cancer?
Yes. Benzene is classified as a Group 1 human carcinogen by the IARC and is directly associated with leukemia, lymphoma, and blood disorders by the CDC, NCI, and DHHS. Long-term exposure is the strongest risk factor. Independent testing found benzene levels in recalled dry shampoos exceeding the FDA’s 2 ppm limit by more than 170 times.
Who may qualify for a Unilever dry shampoo lawsuit?
Individuals who regularly used recalled Unilever dry shampoos Dove, TRESemme, Suave, Nexxus, Bed Head, or Rockaholic between January 1, 2014, and December 31, 2022, and subsequently developed blood cancers or related health conditions may qualify. Eligibility depends on medical evidence, product use documentation, and legal evaluation.
What medical records are most important in a benzene injury claim?
The most critical records include: primary care visit notes documenting symptom onset, hematology and oncology consultation reports, complete blood count (CBC) results over time, bone marrow biopsy pathology, cancer diagnosis and staging reports, treatment records, and occupational or environmental exposure history. A medical record chronology organizes these into a litigation-ready timeline.
Conclusion
The Unilever dry shampoo recall and the subsequent $3.625 million federal class action settlement represent a defining moment in aerosol product safety litigation. With benzene a substance linked to leukemia and life-threatening blood disorders found in millions of consumer products at concentrations exceeding federal limits by more than 170 times, the legal and public health implications are profound.
For attorneys and law firms representing plaintiffs in dry shampoo benzene lawsuits, mass tort engagements, or product liability claims, the evidentiary foundation of every case rests on one core element: the quality and organization of your medical evidence. A professionally prepared medical record review, chronology, and narrative summary does not just support your case, it defines it.
MRR Health Tech stands ready to support your legal team with medico-legal expertise tailored specifically for benzene injury and product recall litigation. Whether you are managing a single plaintiff or a multi-plaintiff mass tort portfolio, our team delivers attorney-ready documentation with accuracy, speed, and full HIPAA compliance.
Ready to Strengthen Your Dry Shampoo or Benzene Injury Case?
About the Author
Will Johnson
Will Johnson is a medico-legal content specialist at MRR Health Tech with extensive experience in product liability documentation, mass tort litigation support, and medical record analysis for legal professionals.
He has contributed to content strategies for law firms handling toxic exposure cases, personal injury claims, and complex multi-plaintiff mass tort engagements across the United States.
His work focuses on translating dense clinical evidence into legally actionable insights that attorneys can use to build stronger, evidence-driven cases.
